Rothfelder, K., Hagelstein, I., Roerden, M., Blumenstock, G., Hofmann, M., Nuebling, T., . . . Dörfel, D. (2018). Expression of the Immune Checkpoint Modulator OX40 in Acute Lymphoblastic Leukemia Is Associated with BCR-ABL Positivity(). Neoplasia.
Citação norma ChicagoRothfelder, Kathrin, Ilona Hagelstein, Malte Roerden, Gunnar Blumenstock, Martin Hofmann, Tina Nuebling, Gundram Jung, Helmut Rainer Salih, and Daniela Dörfel. "Expression of the Immune Checkpoint Modulator OX40 in Acute Lymphoblastic Leukemia Is Associated With BCR-ABL Positivity()." Neoplasia 2018.
MLA citiranjeRothfelder, Kathrin, et al. "Expression of the Immune Checkpoint Modulator OX40 in Acute Lymphoblastic Leukemia Is Associated With BCR-ABL Positivity()." Neoplasia 2018.